Stanford University, 2016, M.S. (expected)
Stanford University, 2007, MD
Harvard University, 2000, BA (Biochemical Sciences)
Acute myeloid leukemia and myelodysplastic syndrome
I develop early-phase clinical trials for patients with AML, specifically testing new drugs and new combinations of drugs. Additionally, I am interested in epidemiological research, using data from patients with AML treated at UW and beyond.